Claim Ownership


Subscribed: 0Played: 0


What do we know about long-Covid? In this captivating episode we listen to the personal and powerful account of how the lingering effects of Sars-CoV-2 has wreaked havoc in an otherwise healthy person “The virus is playing ping-pong with my body”, Norah Casey broadcaster and entrepreneur says when describing all the symptoms in her medically impressive case. Marco Goeijenbier, intensivist and ESWI Board Member together with Merel Hellemons, pulmonologist and researcher with a special interest in long-Covid give an astute description of post-infection syndromes, differences among respiratory virus infections and what is known to date about long-Covid.
Why should older adults be particularly careful of acute respiratory viruses? What are risk factors for adverse outcomes? Why is RSV typically under-diagnosed in adults compared with flu and what are some of the long-term impacts? Are older adults always more at risk in a pandemic?  What do we mean by ageism and what needs to be done to counter it. Listen to this powerful panel of experts, literally spanning the globe, featuring Stefania Maggi ESWI Board Member, Geriatrician and Epidemiologist based in Italy, Kirsty Short, virologist from the University of Queensland Australia, and Jane Barratt, Secretary General, International Federation on Ageing in Canada, shedding light on these questions and more.
The shocking numbers of babies and children who die, or who are in need of care, coupled with the rising number of undiagnosed older adults puts a significant burden from RSV on health systems. The risk of severe RSV illness can be mitigated and thus there is an urgency for increasing awareness of the impact of RSV.Listen to Colin Russell, ESWI Board Member and Professor of Applied Evolutionary Biology, Elizabeth Kuiper, Head of the Social Europe and Well-being programme at the European Policy Centre and George Valiotis, Executive Director of the European Health Management Association expertly untangle the economic and societal impact of acute respiratory viruses with a focus on RSV. They cover everything from air pollution, deep-rooted health inequalities, need for data and surveillance, immunisation programmes, health management to the newly established EU Health Union
Who would have taken virus isolation for granted 30 years ago? How and why did ESWI transform from a pure virology-based network to one encompassing a public health perspective? Join the journey listening to the former, current and future Chairs of ESWI, professors Claude Hannoun, Ab Osterhaus, and Colin Russell reminisce about the past, muse over how ESWI has evolved, and predict where we are heading.Science has advanced significantly. This is a fascinating account and listening to the different perspectives and challenges the three Chairs have and will experience in the field of acute respiratory viruses is truly inspirational.
What do Ebola, Dengue Fever, Lassa Fever, or other hemorrhagic fevers, that often inspire Hollywood productions, have in common with respiratory viruses, such as influenza or Sars-Cov2? Listen to Dr Marco Goeijenbier, intensivist at Spaarne Hospital in Haarlem and ESWI Board Member, expertly explain the complications due to changes in the coagulation system ranging from blood clotting to bleeding. Furthermore, in this captivating account, Marco describes why complications associated with virus infections seem to affect certain risk groups more than others. He clarifies what a super infection is and gives a reflection of how the Covid pandemic personally affected him working in an ICU.
How close are we to a universal flu vaccine? Are universal corona vaccines attainable? What are some of the main challenges facing scientists in their quest to develop these vaccines? Listen to Dr Florian Krammer, Mount Sinai Professor in Vaccinology at the Department of Microbiology at the Icahn School of Medicine, and ESWI Board Member, expertly addressing these questions. Dr Krammer also vividly describes New York in the first few months of the COVID-19 pandemic and explains how and why he rapidly got thousands of followers on Twitter.
In this fascinating episode pathomechanism is explained and we learn how recent research has shown that acute virus infections may cause long-term health impairments. Even mild flu during pregnancy can affect susceptibility to disease in offspring. Listen to the personal experience of life as a scientist, embracing the unknown and how to stay motivated by Guelsah Gabriel, Professor Virology, Leibniz Institute of Virology, Hamburg, Germany and ESWI Board Member including how she integrates the one health concept on a daily basis in all her roles.
Her passion, love and interest to care for children is evident in this personal account by Paula Tähtinen, Clinical Lecturer, Paediatrics and Adolescent Medicine / Adjunct Professor, University of Turku, Finland and ESWI Board Member. The burden of disease from RSV in children is explained along with recommended approaches for both treatment and prevention. She gives a concrete example of how research findings have changed treatment guidelines in paediatrics, providing evidence of the importance of scientific scrutiny. We gain insight in how combining the roles of clinician, lecturer and researcher is mutually supportive and learn about her newly-established research group with a bold vision for the future.
Who is at an increased risk of adverse effects from an RSV infection? What is the burden of disease and what should be done to alleviate the risk and increase awareness?In this captivating episode we listen to Dr. Stefania Maggi, a geriatric epidemiologist and ESWI Board Member answer these and many more questions. She also reflects on the importance of healthy ageing, explains the life-course approach and underlines that older adults are a very heterogeneous group and therefore require a personalised approach to health and diseases.
Why are people with diabetes more at risk from flu? What are the options for reducing the risk? What are the challenges and solutions to increase awareness across health care professionals, researchers and patients themselves? How did COVID-19 change the attention to viral infections in risk groups? Listen to the insightful conversation among the experts and members of the Influenza Diabetes Community (IDC), Dr Marco Goeijenbier, Chair IDC, ESWI Board Member and medical doctor intensive care and medicine, together with Dr Kirsty Short, research fellow and head of the viral pathogenesis lab at the School of Chemistry and Molecular Biosciences, The University of Queensland, and Dan Howard, diabetes specialist nurse and Head of Care for Diabetes UK
With a wealth of experience, Professor of Epidemiology and former Minister of Health, ESWI Board Member Roman Prymula gives a personal testimony of the COVID-19 pandemic and the different perspectives of politics vs science when it comes to health policy. Insights into vaccinology, the rise of anti-vaxxers and views on how to counter vaccine-hesitancy contribute to this engaging episode.
The dynamic interplay between epidemiological research, virus evolution, and mathematical modelling is skilfully described by Dr Colin Russell, Professor of Applied Evolutionary Biology and ESWI Board Member. Flu was Prof. Russell’s first love, however the complex epidemiological pathways of the COVID-19 pandemic sparked his interest in how mathematical modelling informs pandemic response particularly in LMICs.
What do snowflakes and viruses have in common? What is the scientific value of analysing “wild and wacky” forms of viruses? And what does a biomedical illustrator really do? These, and many more questions are addressed in this captivating episode delving into the scientific world of biomedical visualisation by Dr Ed Hutchinson,  ESWI Board Member and senior lecturer at the MRC-University of Glasgow Centre for Virus Research and invited guest Sarah Iannucci.
"Learn about the fascinating field of mucosal immunology, vaccine effectiveness, and the role of face-mask protection not from virus particles but “spiticles and snoticles”. Dr Peter Openshaw, ESWI Board Member and Professor of Experimental Medicine, Imperial College London, expertly guides us through what led to the unprecedented speed of COVID-19 vaccine development. From his experience of two pandemics, he offers a vision of future variants and how SARS-COV-2 is continuing to evolve.”This podcast is kindly sponsored by Viatris. 
ESWI Board Member Terho Heikkinen, Professor in paediatrics at the University of Turku in Finland talks about paediatric infectious diseases. Learn about why the flu shot is to be recommended in children.This podcast is kindly sponsored by Viatris. 
ESWI Chair and Professor in Virology, Ab Osterhaus, gives a captivating explanation on why we need to stay vigilant and properly prepare for the next pandemic.This podcast is kindly sponsored by Viatris. 
ESWI Board Member and retired general practitioner Ted van Essen describes his unique journey from studying the benefits of influenza vaccination to risk groups to becoming “Dr Ted” on Dutch television, and having this important role in bringing accurate information about influenza vaccination to the general public. This podcast is kindly sponsored by Viatris. 
Dr George Kassianos, ESWI Board Member and retired general practitioner gives a comprehensive and in-depth explanation of vaccination and pregnancy, including the risks and benefits to the mother and the infant.  All the important vaccines are covered including Covid-19, influenza, MMR, and others. This podcast is kindly sponsored by Viatris. 
Download from Google Play
Download from App Store